Target intelligence / Profile preview

Mitochondrial glycerol-3-phosphate dehydrogenase and Mitochondrial complex I (NADH:ubiquinone oxidoreductase) (GPD2 and NDUFS1/Complex I)

Target
GPD2 and NDUFS1/Complex I
Molecular classification
Enzyme, Oxidoreductase, Flavoprotein, Mitochondrial membrane protein, Mitochondrial respiratory chain complex, Multisubunit membrane protein
01

Overview

Mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH, GPD2) is an inner mitochondrial membrane–bound flavoprotein that catalyzes the oxidation of glycerol-3-phosphate to dihydroxyacetone phosphate, transferring electrons from FADH2 to ubiquinone and thus into the electron transport chain. It is a key component of the glycerol phosphate shuttle, linking glycolytic NADH production with mitochondrial respiration and contributing to cellular redox balance, fatty acid metabolism, and thermogenic regulation, particularly in brown adipose tissue. Mitochondrial complex I (NADH:ubiquinone oxidoreductase) is the largest enzyme complex of the mitochondrial respiratory chain. It catalyzes the transfer of electrons from NADH to ubiquinone (CoQ10), coupled to the pumping of protons across the inner mitochondrial membrane, which is essential for driving ATP synthesis via oxidative phosphorylation. Complex I consists of multiple subunits organized into a large L-shaped structure with modular domains for electron transfer and proton translocation. Dysfunction or inhibition of complex I is implicated in a range of metabolic, neurodegenerative, and cardiovascular diseases. Both enzymes play vital—but distinct—roles in mitochondrial metabolism, with mGPDH providing electrons via FADH2 to the respiratory chain and complex I providing electrons from NADH, converging at ubiquinone as the electron acceptor.

Other names
mGPDHGPD2sn-glycerol-3-phosphate dehydrogenase (mitochondrial)glycerolphosphate dehydrogenase 2NADH:ubiquinone oxidoreductaseNADH dehydrogenase (ubiquinone)respiratory complex I
02

Mechanism of action

mGPDH inhibitors: Block transfer of electrons from glycerol-3-phosphate to electron transport chain, disrupting NAD+/NADH balance and glycolytic flux. Complex I inhibitors: Prevent electron transfer from NADH to ubiquinone, disrupt proton gradient, impairing ATP production and promoting cell death in susceptible cells.

03

Biological functions

Mitochondrial redox balance and NAD+/NADH regenerationGlycerol phosphate shuttle (links glycolysis, lipid metabolism, and mitochondrial respiration)Fatty acid metabolismElectron transfer from NADH to ubiquinone (CoQ10)Initiation of mitochondrial electron transport chainProton translocation/Proton motive force generationATP synthesis
04

Disease associations

Metabolic disorders (e.g., diabetes, obesity)Cardiovascular diseaseNeurodegenerative disease (via redox stress and ROS)Neurodegenerative diseases (Parkinson’s, mitochondrial myopathies)Ischemia-reperfusion injuryCancerMetabolic syndromes
05

Safety considerations

Mitochondrial toxicity (energy failure, lactic acidosis)Excess ROS production (with complex I inhibition)Tissue specificity (e.g., heart, brain highly vulnerable to complex I inhibition)On-target toxicity (because these enzymes support basic cellular metabolism in most tissues)
06

Interacting drugs

Novel small-molecule inhibitors (benzimidazole-phenyl-succinamide class, e.g., iGP-1, iGP-5)

5 more in the full profile.

07

Biomarkers

Altered NAD+/NADH ratiosATP/ADP levelsMitochondrial respiratory complex activitiesROS (reactive oxygen species) productionBioenergetic signature (e.g., beta-F1-ATPase/GAPDH ratio in cancer)

Beyond the preview

Go deeper on Mitochondrial glycerol-3-phosphate dehydrogenase and Mitochondrial complex I (NADH:ubiquinone oxidoreductase) (GPD2 and NDUFS1/Complex I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial glycerol-3-phosphate dehydrogenase and Mitochondrial complex I (NADH:ubiquinone oxidoreductase) (GPD2 and NDUFS1/Complex I).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call